153 related articles for article (PubMed ID: 33159698)
1. Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer.
Han X; Ma L; Gu J; Wang D; Li J; Lou W; Saiyin H; Fu D
J Pathol; 2021 Mar; 253(3):304-314. PubMed ID: 33159698
[TBL] [Abstract][Full Text] [Related]
2. The physiological characteristics of the basal microvilli microvessels in pancreatic cancers.
Ma L; Han X; Gu J; Li J; Lou W; Jin C; Saiyin H
Cancer Med; 2020 Aug; 9(15):5535-5545. PubMed ID: 32488986
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.
Hexige S; Ardito-Abraham CM; Wu Y; Wei Y; Fang Y; Han X; Li J; Zhou P; Yi Q; Maitra A; Liu JO; Tuveson DA; Lou W; Yu L
J Pathol; 2015 Jun; 236(2):142-154. PubMed ID: 25561062
[TBL] [Abstract][Full Text] [Related]
4. Feeding cancer's sweet tooth: specialized tumour vasculature shuttles glucose in pancreatic ductal adenocarcinoma.
Dudley AC; Bautch VL
J Pathol; 2015 Jun; 236(2):133-5. PubMed ID: 25727340
[TBL] [Abstract][Full Text] [Related]
5. VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
Morin E; Sjöberg E; Tjomsland V; Testini C; Lindskog C; Franklin O; Sund M; Öhlund D; Kiflemariam S; Sjöblom T; Claesson-Welsh L
J Pathol; 2018 Nov; 246(3):311-322. PubMed ID: 30027561
[TBL] [Abstract][Full Text] [Related]
6. CT contrast enhancement correlates with pathological grade and microvessel density of pancreatic cancer tissues.
Wang SH; Sun YF; Liu Y; Zhou Y; Liu Y
Int J Clin Exp Pathol; 2015; 8(5):5443-9. PubMed ID: 26191248
[TBL] [Abstract][Full Text] [Related]
7. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma.
Jureidini R; da Cunha JE; Takeda F; Namur GN; Ribeiro TC; Patzina R; Figueira ER; Ribeiro U; Bacchella T; Cecconello I
Clinics (Sao Paulo); 2016 Jul; 71(6):315-9. PubMed ID: 27438564
[TBL] [Abstract][Full Text] [Related]
9. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
[TBL] [Abstract][Full Text] [Related]
10. High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade.
Barău A; Ruiz-Sauri A; Valencia G; Gómez-Mateo Mdel C; Sabater L; Ferrandez A; Llombart-Bosch A
Virchows Arch; 2013 May; 462(5):541-6. PubMed ID: 23579431
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of
Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
[TBL] [Abstract][Full Text] [Related]
12. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis.
Hsu CC; Liao WY; Chan TS; Chen WY; Lee CT; Shan YS; Huang PJ; Hou YC; Li CR; Tsai KK
J Pathol; 2019 Dec; 249(4):498-508. PubMed ID: 31465125
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas.
Amato E; Mafficini A; Hirabayashi K; Lawlor RT; Fassan M; Vicentini C; Barbi S; Delfino P; Sikora K; Rusev B; Simbolo M; Esposito I; Antonello D; Pea A; Sereni E; Ballotta M; Maggino L; Marchegiani G; Ohike N; Wood LD; Salvia R; Klöppel G; Zamboni G; Scarpa A; Corbo V
J Pathol; 2019 Jan; 247(1):123-134. PubMed ID: 30306561
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Metabolic Tumor Volume
Lee SH; Hwang HK; Lee WJ; Yun M; Kang CM
Gut Liver; 2019 May; 13(3):356-365. PubMed ID: 30602217
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.
Dreijerink KM; Hackeng WM; Singhi AD; Heaphy CM; Brosens LA
J Pathol; 2022 Feb; 256(2):143-148. PubMed ID: 34750813
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling.
Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S
Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis: a prognostic determinant in pancreatic cancer?
van der Zee JA; van Eijck CH; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; ten Hagen TL
Eur J Cancer; 2011 Nov; 47(17):2576-84. PubMed ID: 21958461
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma.
Esposito I; Menicagli M; Funel N; Bergmann F; Boggi U; Mosca F; Bevilacqua G; Campani D
J Clin Pathol; 2004 Jun; 57(6):630-6. PubMed ID: 15166270
[TBL] [Abstract][Full Text] [Related]
20. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
